Result card

  • ORG10: What are the likely budget impacts of implementing the technologies being compared?
Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment
G0007
English
Guidance Resources

What are the likely budget impacts of implementing the technologies being compared?

Authors: Pseudo117 Pseudo117, Pseudo451 Pseudo451, Pseudo136 Pseudo136, Pseudo262 Pseudo262

Internal reviewers: Pseudo291 Pseudo291, Pseudo340 Pseudo340

None of our included studies provided information on this topic.

Pseudo117 P et al. Result Card ORG10 In: Pseudo117 P et al. Organisational aspects In: Jefferson T, Cerbo M, Vicari N [eds.]. Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 7 February 2023]. Available from: http://corehta.info/ViewCover.aspx?id=267